Additionally, NHE1 protein blockade promoted an immunogenic tumor microenvironment by inducing the accumulation of CD8 T cells, enhancing interferon-gamma (IFN-γ) expression, and rendering animals sensitive to anti-PD-1 treatment [66]. This evidence concerns the gene IFNG and neoplasm.